Inventor
SIADAK ANTHONY W
US35 patents
⚠️ This page may combine multiple inventors who share the name “SIADAK ANTHONY W”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ZYMOGENETICS INC
15 patentsUS7531637B2May 12, 2009
IL-31 monoclonal antibodies
ZYMOGENETICS INC87 citations98
US10434173B2Oct 8, 2019
Use of IL-31 monoclonal antibodies for treating pruritus
ZYMOGENETICS INC49 citations97
US9878038B2Jan 30, 2018
Methods of treating atopic dermatitis with IL-31 monoclonal antibodies
ZYMOGENETICS INC55 citations97
US9624296B2Apr 18, 2017
Polynucleotides encoding IL-31 monoclonal antibodies
ZYMOGENETICS INC51 citations97
US9011858B2Apr 21, 2015
Variable region sequences of IL-31 monoclonal antibodies and methods of use
ZYMOGENETICS INC62 citations97
US8017122B2Sep 13, 2011
Methods of using IL-31 monoclonal antibodies to reduce inflammation
ZYMOGENETICS INC69 citations97
US9683037B2Jun 20, 2017
Method of treating atopic dermatitis with IL-31 monoclonal antibodies
ZYMOGENETICS INC10 citations92
US9156909B2Oct 13, 2015
Polynucleotides encoding IL-31 monoclonal antibodies
ZYMOGENETICS INC16 citations92
US7537761B2May 26, 2009
Anti-IL-22RA antibodies and binding partners and methods of using in inflammation
ZYMOGENETICS INC18 citations92
US7393684B2Jul 1, 2008
Immunoconjugates of anti-IL-20 antibodies and hybridoma cell lines expressing anti-IL-20 antibodies
ZYMOGENETICS INC25 citations92
US10259868B2Apr 16, 2019
Methods of treating atopic dermatitis with IL-31 monoclonal antibodies
ZYMOGENETICS INC4 citations84
US9512219B2Dec 6, 2016
IL-31 monoclonal antibodies
ZYMOGENETICS INC8 citations84
US9822177B2Nov 21, 2017
Method of reducing pruritus using IL-31 monoclonal antibodies
ZYMOGENETICS INC14 citations83
US10273297B2Apr 30, 2019
Use of IL-31 monoclonal antibodies for reducing pruritus
ZYMOGENETICS INC5 citations72
US7871616B2Jan 18, 2011
Anti-IL-22RA antibodies and binding partners and methods of using in inflammation
ZYMOGENETICS INC1 citations62
BRISTOL MYERS SQUIBB CO
10 patentsUS6051228AApr 18, 2000
Antibodies against human CD40
BRISTOL MYERS SQUIBB CO202 citations97
US6210669B1Apr 3, 2001
Methods and compositions for immunomodulation
BRISTOL MYERS SQUIBB CO194 citations96
US5876950AMar 2, 1999
Monoclonal antibodies specific for different epitopes of human GP39 and methods for their use in diagnosis and therapy
BRISTOL MYERS SQUIBB CO115 citations95
US6372215B1Apr 16, 2002
Monoclonal antibodies to human CD6
BRISTOL MYERS SQUIBB CO55 citations93
US6413514B1Jul 2, 2002
Methods of using antibodies against human CD40
BRISTOL MYERS SQUIBB CO35 citations91
US5662905ASep 2, 1997
Monoclonal antibody compositions cross-reactive and cross-protective against P. aeruginosa serotypes
BRISTOL MYERS SQUIBB CO12 citations81
US5628996AMay 13, 1997
Method for inhibiting the viability of Pseudomonas aeruginosa with cross-reactive and cross-protective monoclonal antibodies
BRISTOL MYERS SQUIBB CO4 citations72
US5627067AMay 6, 1997
Monoclonal antibodies cross-reactive and cross-protective against human monoclonal antibodies against pseudomonas aeruginosa serotypes
BRISTOL MYERS SQUIBB CO9 citations72
US5378812AJan 3, 1995
Monoclonal antibodies cross-reactive and cross-protective against P. aeruginosa serotypes
BRISTOL MYERS SQUIBB CO4 citations72
US6046314AApr 4, 2000
Spα: a novel scavenger receptor cysteine-rich domain-containing polypeptide, and monoclonal antibodies thereto
BRISTOL MYERS SQUIBB CO7 citations68
XU WENFENG
4 patentsUS8163286B2Apr 24, 2012
Anti-IL-22RA antibodies and binding partners and methods of using in inflammation
XU WENFENG2 citations61
US8124088B2Feb 28, 2012
Methods of treatment using anti-IL-22RA antibodies
XU WENFENG3 citations61
US8536309B2Sep 17, 2013
Methods of producing anti-IL-22RA antibodies
XU WENFENG0 citations51
US8907068B2Dec 9, 2014
Anti-IL-20 antibodies and binding partners and methods of using in inflammation
XU WENFENG0 citations49
SIADAK ANTHONY W
3 patentsUS8466262B2Jun 18, 2013
Variable region sequences of IL-31 monoclonal antibodies and methods of use
SIADAK ANTHONY W106 citations97
US8568723B2Oct 29, 2013
Method of reducing pruritis using IL-31 monoclonal antibodies
SIADAK ANTHONY W26 citations91
US8101183B2Jan 24, 2012
Variable region sequences of IL-31 monoclonal antibodies
SIADAK ANTHONY W38 citations91